Method for clustering photos for pictoral storytelling
US-2024419384-A1 · Dec 19, 2024 · US
US12019674B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12019674-B2 |
| Application number | US-202016887036-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 29, 2020 |
| Priority date | May 29, 2019 |
| Publication date | Jun 25, 2024 |
| Grant date | Jun 25, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of treating a subject comprises administering a treatment to a subject identified as having a high probability of distant metastatic recurrence, wherein the probability of distant metastatic recurrence was determined by a process, comprising acquiring at least one image of a tissue sample comprising a plurality of cells, taken from a subject, classifying each of the plurality of cells into categories, dividing the at least one image into a plurality of patches, calculating values for a plurality of morphological features based on the patches, and calculating a distant metastatic recurrence probability based on the values. A computer-implemented method of training a neural network and a system for characterizing a cancer in a subject are also described.
Opening claim text (preview).
What is claimed is: 1. A method of treating a subject by administering a treatment to a subject identified as having a high probability of distant metastatic recurrence, wherein the probability of distant metastatic recurrence was determined by a process, comprising: acquiring at least one image of a tissue sample comprising a plurality of cells, taken from a subject; classifying each of the plurality of cells into categories; dividing the at least one image into a plurality of patches, each patch comprising multiple cells of the plurality of cells; assigning cells in each of the plurality of patches to one or more clusters using a clustering algorithm to produce clustering data for each patch, the clustering data comprising a cluster size; calculating a cell density of each of the plurality of patches; calculating values for a plurality of morphological features based on the patches; and calculating a distant metastatic recurrence probability based on the values, the cell density, and the clustering data. 2. The method of claim 1 , wherein the patches are acquired at least in part by random sampling. 3. The method of claim 1 , wherein the categories comprise tumor cells, non-tumor cells, or immune cells. 4. The method of claim 1 , further comprising identifying a subset of the patches of the image meeting a criterion selected from the group consisting of no cells appearing in the patch and no tumor cells appearing in the patch; and discarding the subset of patches. 5. The method of claim 1 , wherein the distant metastatic recurrence probability is calculated by at least one neural network. 6. The method of claim 1 , wherein the patches are selected by calculating a cell density and comparing the cell density to a threshold. 7. The method of claim 1 , wherein the morphological features comprise at least one of (Count of immune cells in “large” cluster)/(Total count of immune cells); (Count of immune cells in “large” cluster)/(Total count of tumor+immune); (Count of immune cells in “large” cluster)/(Count of tumor cells in “large” cluster); (Count of immune cells in “large” cluster)/(Count of immune cells in “small” cluster); (Total count of immune cells)/(Total count of tumor+immune); (Immune cell total area)/(Tumor cell total area); and (Immune cell total area)/(Total Immune area+Tumor area). 8. The method of claim 1 , wherein the distant metastatic recurrence probability is calculated by aggregating a set of votes for each patch in the plurality of patches based on the values. 9. The method of claim 1 , wherein the at least one image comprises at least first and second images, the first and second images acquired from different body regions of the subject. 10. The method of claim 1 , wherein the treatment is selected from the group consisting of Nivolumab, Perbrolizumab, Ipilimumab, Dabrafenib, Trametinib, Vermurafenib, high-dose interferon alfa, chemotherapy, surgical excision, and immunotherapy.
characterised by memory or gating, e.g. long short-term memory [LSTM] or gated recurrent units [GRU] · CPC title
Convolutional networks [CNN, ConvNet] · CPC title
Supervised learning · CPC title
Matching; Classification · CPC title
using classification, e.g. of video objects · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.